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A new two-group deterministic model for Chlamydia trachomatis is designed and analyzed
to gain insights into its transmission dynamics. The model is shown to exhibit the phe-
nomenon of backward bifurcation, where a stable disease-free equilibrium (DFE) co-exists
with one or more stable endemic equilibria when the associated reproduction number is
less than unity. It is further shown that the backward bifurcation dynamic is caused by the
re-infection of individuals who recovered from the disease. The epidemiological implica-
tion of this result is that the classical requirement of the reproduction number being less
than unity becomes only a necessary, but not suﬃcient, condition for disease elimination.
The basic model is extended to incorporate the use of treatment for infectious individuals
(including those who show disease symptoms and those who do not). Rigorous analysis
of the treatment model reveals that the use of treatment could have positive or nega-
tive population-level impact, depending on the sign of a certain epidemiological threshold.
The treatment model is used to evaluate various treatment strategies, namely treating
every infected individual showing symptoms of Chlamydia (universal strategy), treating
only infectious males showing Chlamydia symptoms (male-only strategy) and treating only
infectious females showing symptoms of Chlamydia (female-only strategy). Numerical sim-
ulations show that the implementation of the male-only or female-only strategy can induce
an indirect beneﬁt of saving new cases of Chlamydia infection in the opposite sex. Further,
the universal strategy gives the highest reduction in the cumulative number of new cases
of infection.
© 2009 Elsevier Inc. All rights reserved.
1. Introduction
Chlamydia is a sexually-transmitted disease (STD), caused by the bacterium Chlamydia trachomatis. It is the common-
est sexually-transmitted bacterial disease in European countries [6,17] and United States [19,28]. The family Chlamydiaceae
consists of one genus Chlamydia with three species that cause disease in humans, namely Chlamydia trachomatis, Chlamy-
dia pneumoniae and Chlamydia psittaci. Of these three, only Chlamydia trachomatis is sexually transmitted (via vaginal, oral
and anal sex). Chlamydia trachomatis is transmitted through other modes, such as vertically (from mother-to-child) [4]. The
symptoms of Chlamydia are usually mild or absent (three quarters of infected women and about half of infected men do not
show symptoms). This, in turn, may result in the occurrence of serious Chlamydia-associated irreversible complications [4],
such as chronic pelvic pain, infertility in females (untreated infection can spread into the uterus or fallopian tubes and cause
pelvic inﬂammatory disease (PID), which can cause permanent damage to the fallopian tubes, uterus, and surrounding tis-
sues) and potentially fatal ectopic pregnancy (pregnancy outside the uterus), before the problem is diagnosed. If symptoms
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O. Sharomi, A.B. Gumel / J. Math. Anal. Appl. 356 (2009) 96–118 97do occur, they usually appear within 1–3 weeks after exposure [4]. Women are frequently re-infected if their sex partners
are not treated [4]. Complications in male usually includes penile discharges or a burning sensation when urinating.
In 2006, up to 4–5 million cases of Chlamydia were reported in the United States [13]. In 2002, Chlamydia claimed the
lives of 1000 people in Africa, 1000 in Eastern Mediterranean and 8000 in South East Asia (the World Health Report [33]).
The annual cost of Chlamydia and its consequences in the United States alone is more than $2 billion (see [31] and the
references therein). Under-reporting is substantial because most people with Chlamydia are not aware of their infections
and do not seek testing. The fact that such individuals with no symptoms can transmit the disease to susceptible humans
makes Chlamydia a major public health menace. Recent scientiﬁc study has shown that sensitive electrochemical DNA
detection method can be used for the diagnosis of STDs caused by Chlamydia trachomatis [38].
Fortunately, however, if diagnosed effectively, Chlamydia can be easily treated and cured using antibiotics. A single dose
of azithromycin or a week of doxycycline (twice daily) are the most commonly used treatments. Detailed information from
the Centers for Disease Control (CDC) [4,33] revealed that individuals can be infectious and yet not show any symptoms
of the disease. Another important fact about Chlamydia is that infected individuals can acquire re-infection while recov-
ering from the disease [4]. This often arises in situations were individuals have multiple sex partners. In order to avoid
re-infection, all sex partners should be evaluated, tested, and treated. Infected individuals should abstain from sexual inter-
course until they, and their sex partners, have completed treatment. Re-testing 3–4 months after treatment is necessary for
individuals with multiple sex partners and for those not sure if their sex partner has received treatment. The most effective
way to avoid the transmission of Chlamydia is to abstain from sexual contact if possible, or to be in a long-term mutu-
ally monogamous relationship with a partner who has been tested and is known to be uninfected. Latex male condoms,
when used consistently and correctly, can reduce the risk of transmission of Chlamydia. Other recommendation from CDC
to help reduce the public health burden of Chlamydia includes yearly Chlamydia testing of all sexually-active women age
25 or younger, older women with risk factors for Chlamydia infections (those who have a new sex partner or multiple sex
partners), and all pregnant women [4]. There is currently no effective vaccine against Chlamydia, but efforts are underway
to develop one (see, for instance, [33]).
The enormous public health burden inﬂicted by Chlamydia disease necessitates the use of mathematical modelling and
analysis to gain insights into its transmission dynamics, and to determine effective control strategies. The literature on the
use of mathematical modelling in Chlamydia transmission dynamics is rather scant. A few population-level models, of the
form of discrete-time [18,21] and continuous-time [3,26] dynamical systems, have been presented. In-host models for the
dynamics of Chlamydia are presented in [2,5,35–37]. Other forms of Chlamydia modeling involve the use of individual-
based stochastic model [20,32]. This study complements the aforementioned studies (particularly the population models in
[3,18,21,26]) by designing a new comprehensive continuous-time deterministic, two-group model for the spread and control
of the Chlamydia in a population. Some of the new features of the model include (i) addition of 10 new epidemiological
compartments; (ii) incorporation of re-infection of recovered individuals; (iii) allowing for disease transmission by exposed
individuals. Further, rigorous qualitative analysis of the resulting models is provided. It is worth emphasizing that mathe-
matical analysis of biomedical and disease transmission models can contribute to the understanding of the mechanisms of
those processes and to design potential therapies (see, for example, [1,7,8,10,14,16,27,39–41] and the references therein).
The paper is organized as follows. A basic Chlamydia model is formulated and rigorously analyzed in Section 2. The
model is extended to include the use of treatment in Section 3. Numerical simulations are reported in Section 4.
2. Formulation of basic model
The total sexually-active population at time t , denoted by N(t), is divided into 2 classes, namely the total male popula-
tion (Nm(t)) and the total female population (N f (t)), respectively. The total male population is further sub-divided into 5
mutually-exclusive compartments: susceptible males (Sm(t)), exposed males (Em(t)), infectious males showing symptoms of
Chlamydia (Im(t)), infectious males showing no symptoms of Chlamydia (Am(t)) and infectious males who have cleared (or
recovered from) Chlamydia infection (Rm(t)). Similarly, the total female population is sub-divided into susceptible females
(S f (t)), exposed females (E f (t)), infectious females showing symptoms of Chlamydia (I f (t)), infectious females with no
symptoms of Chlamydia (A f (t)) and infectious females who have cleared (or recovered from) Chlamydia infection (R f (t)).
Thus,
N(t) = Nm(t) + N f (t),
Nm(t) = Sm(t) + Em(t) + Im(t) + Am(t) + Rm(t),
N f (t) = S f (t) + E f (t) + I f (t) + A f (t) + R f (t).
The susceptible populations (for both males and females) are increased by the recruitment of new sexually-active individuals
(assumed susceptible) into the population at a rate Πm and Π f for the male and female population, respectively. Susceptible
males acquire Chlamydia infection and become exposed, following effective contact with infected females (i.e., those in the
E f , I f and A f classes), at a rate λ f , given by
λ f (t) = cmβ f [E f (t) + θ1 I f (t) + θ2A f (t)]N (t) . (1)f
98 O. Sharomi, A.B. Gumel / J. Math. Anal. Appl. 356 (2009) 96–118Similarly, susceptible females acquire Chlamydia infection following effective contact with males infected with Chlamydia
(i.e., those in the Em , Im and Am classes) at a rate λm , given by
λm(t) = c f βm[Em(t) + θ1 Im(t) + θ2Am(t)]
Nm(t)
. (2)
In (1) and (2), βm and β f are the probabilities of transmitting Chlamydia from male-to-female and female-to-male, respec-
tively. The terms cm and c f represent the rates at which males and females acquire new sexual partners, respectively. Thus,
c f βm and cmβ f are the effective contact rates for male-to-female and female-to-male transmission of Chlamydia, respec-
tively. Further, the modiﬁcation parameters θ1 > 1 and θ2 > 1 (with θ1 = θ2) account for the assumed increase in the relative
infectiousness of individuals in the Im and I f (infectious individuals showing symptoms of Chlamydia) and Am and A f (in-
fectious individuals showing no symptoms of Chlamydia) classes in comparison to exposed males and females (in the Em
and E f classes), respectively. That is, it is assumed that infected females in the I f and A f classes are more infectious than
infected females in the E f class (similarly, infected males in the Im and Am classes are assumed to be more infectious
than infected males in the Em class). After 1–3 weeks of becoming exposed to Chlamydia infection, such individuals will
become infectious at a rate ρm (ρ f ) for males (females). A fraction κm (κ f ) of these individuals will start to show symp-
toms of Chlamydia infection (and move to the class Im (I f )), while the remaining fraction, (1− κm) (1− κ f ), will not (but
still remain capable of infecting others). Infectious individuals that do not initially show symptoms (i.e., those in the Am
and A f classes) are expected to suffer severe complications, such as infertility, if untreated. However, they eventually show
symptoms at a rate (1− φm)γm ((1− φ f )γ f ) for the male (female) population, while the remaining fraction, φmγm (φ f γ f ),
recovers naturally (cleared the infection; see [22,24] for discussion on clearance rate of Chlamydia). Infectious individuals
showing symptoms of Chlamydia clear infections at rates θm (θ f ) for male (female) population. Recovered individuals can
be re-infected at rates rmλ f (t) and r f λm(t) for males and females, respectively, with rm > 0 and r f > 0 representing the
re-infection parameters for males and females (see [9] for discussion on re-infection of Chlamydia among female adoles-
cents), respectively and they can lose their acquired immunity at a rate ψm (ψ f ) for males (females) and return to the
corresponding susceptible class Sm (S f ).
Further, natural mortality occurs in all classes at a rate μ, while individuals in the Im , Am and I f , A f classes suffer
an additional disease-induced death at rates δm and δ f , respectively. Combining all these deﬁnitions and assumptions, it
follows that the basic model for the transmission of Chlamydia in a sexually-active population is given by the following
system of differential equations:
dSm
dt
= Πm + ψmRm(t) − λ f (t)Sm(t) − μSm(t),
dEm
dt
= λ f (t)Sm(t) + rmλ f (t)Rm(t) − (μ + ρm)Em(t),
dIm
dt
= κmρmEm(t) + (1− φm)γmAm(t) − (μ + δm + θm)Im(t),
dAm
dt
= (1− κm)ρmEm(t) − (μ + δm + γm)Am(t),
dRm
dt
= θmIm(t) + φmγmAm(t) −
(
μ + ψm + rmλ f (t)
)
Rm(t),
dS f
dt
= Π f + ψ f R f (t) − λm(t)S f (t) − μS f (t),
dE f
dt
= λm(t)S f (t) + r f λm(t)R f (t) − (μ + ρ f )E f (t),
dI f
dt
= κ f ρ f E f (t) + (1− φ f )γ f A f (t) − (μ + δ f + θ f )I f (t),
dA f
dt
= (1− κ f )ρ f E f (t) − (μ + δ f + γ f )A f (t),
dR f
dt
= φ f γ f A f (t) + θ f I f (t) −
(
μ + ψ f + r f λm(t)
)
R f (t). (3)
The group contact constraint is given by
cmNm = c f N f , (4)
a consistency condition which simply states that in any small time interval [t, t + t], the total number of partnerships
formed by females with males must equal total number of partnerships formed by males with females.
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2.1.1. Positivity and boundedness of solutions
For the basic model (3) to be epidemiologically meaningful, it is important to prove that all its state variables are non-
negative for all time. In other words, solutions of the model system (3) with positive initial data will remain positive for all
time t > 0.
Theorem 1. Let the initial data Sm(0) > 0, Em(0) > 0, Im(0) > 0, Am(0) > 0, Rm(0) > 0, S f (0) > 0, E f (0) > 0, I f (0) > 0,
A f (0) > 0, R f (0) > 0. Then the solutions (Sm, Em, Im, Am, Rm, S f , E f , I f , A f , R f ) of the basic model (3) are positive for all t > 0.
Furthermore,
limsup
t→∞
Nm(t)
Πm
μ
and limsup
t→∞
N f (t)
Π f
μ
,
with
Nm = Sm + Em + Im + Am + Rm, and N f = S f + E f + I f + A f + R f .
Proof. Let t1 = sup{t > 0: Sm > 0, Em > 0, Im > 0, Am > 0, Rm > 0, S f > 0, E f > 0, I f > 0, A f > 0, R f > 0 ∈ [0, t]}.
Thus, t1 > 0. It follows, from the ﬁrst equation of the system (3), that
dSm
dt
= Πm + ψmRm(t) − λ f (t)Sm(t) − μSm(t)Πm −
[
λ f (t) + μ
]
Sm(t),
which can be re-written as
d
dt
[
Sm(t)exp
{ t∫
0
λ f (u)du + μt
}]
Πm exp
{ t∫
0
λ f (u)du + μt
}
.
Hence,
Sm(t1)exp
{ t1∫
0
λ f (u)du + μt1
}
− Sm(0)
t1∫
0
Πm exp
{ x∫
0
λ f (ν)dν + μx
}
dx,
so that
Sm(t1) Sm(0)exp
{
−
t1∫
0
λ f (u)du + μt1
}
+ exp
{
−
t1∫
0
λ f (u)du + μt1
}
×
t1∫
0
Πm exp
{ x∫
0
λ f (ν)dν + μx
}
dx
> 0.
Similarly, it can be shown that Em > 0, Im > 0, Am > 0, Rm > 0, S f > 0, E f > 0, I f > 0, R f > 0 and A f > 0 for all time
t > 0. For the second part of the proof, it should be noted that 0< Im(t) Nm(t), 0 < Am(t) Nm(t), 0 < I f (t) N f (t) and
0 < A f (t) N f (t).
Adding the ﬁrst ﬁve and the last ﬁve equations in the differential equation system (3) gives
dNm
dt
= Πm − μNm(t) − δm
[
Im(t) + Am(t)
]
,
dN f
dt
= Π f − μN f (t) − δ f
[
I f (t) + A f (t)
]
. (5)
It follows from (5) that
Πm − (μ + 2δm)Nm(t) dNm
dt
< Πm − μNm(t),
Π f − (μ + 2δ f )N f (t) dN fdt < Π f − μN f (t).
Thus,
Πm
μ + 2δm  lim inft→∞ Nm(t) limsupt→∞ Nm(t)
Πm
μ
,
and
Π f
μ + 2δ  lim inft→∞ N f (t) limsupN f (t)
Π f
μ
,f t→∞
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limsup
t→∞
Nm(t)
Πm
μ
and limsup
t→∞
N f (t)
Π f
μ
,
as required. 
2.1.2. Invariant regions
The two-sex model (3) will be analyzed in a biologically-feasible region as follows. We ﬁrst show that the system (3)
is dissipative (i.e., all feasible solutions are uniformly-bounded in a proper subset D ⊂ R10+ ). The system (3) is split into
two parts, namely the male population (Nm) (with Nm = Sm + Em + Im + Am + Rm) and the female population (N f ) (with
N f = S f + E f + I f + A f + R f ). Consider the feasible region
D = Dm ∪ D f ⊂R5+ ×R5+,
with
Dm =
{
(Sm, Em, Im, Am, Rm) ∈R5+: Sm + Em + Im + Am + Rm 
Πm
μ
}
,
and
D f =
{
(S f , E f , I f , A f , R f ) ∈R5+: S f + E f + I f + A f + R f 
Π f
μ
}
.
The following steps are followed to establish the positive invariance of D (i.e., solutions in D remain in D for all t  0). It
follows from (5) that
dNm
dt
Πm − μNm(t),
dN f
dt
Π f − μN f (t). (6)
A standard comparison theorem [15] can then be used to show that Nm(t)  Nm(0)e−μt + Πmμ (1 − e−μt) and N f (t) 
N f (0)e−μt + Π fμ (1 − e−μt). In particular, Nm(t)  Πmμ and N f (t) 
Π f
μ if Nm(0) 
Πm
μ and N f (0) 
Π f
μ , respectively. Thus,
the region D is positively-invariant. Hence, it is suﬃcient to consider the dynamics of the ﬂow generated by (3) in D. In this
region, the model can be considered as been epidemiologically and mathematically well-posed [12]. Thus, every solution of
the basic model (3) with initial conditions in D remains in D for all t > 0. Therefore, the ω-limit sets of the system (3) are
contained in D. This result is summarized below.
Lemma 1. The region D = Dm ∪ D f ⊂R5+ ×R5+ is positively-invariant for the basic model (3) with initial conditions in R10+ .
2.2. Stability of disease-free equilibrium (DFE)
2.2.1. Local stability
The basic model (3) has a DFE, obtained by setting the right-hand sides of the equations in the model to zero, given by
E0 =
(
S∗m, E∗m, I∗m, A∗m, R∗m, S∗f , E
∗
f , I
∗
f , A
∗
f , R
∗
f
)= (Πm
μ
,0,0,0,0,
Π f
μ
,0,0,0,0
)
. (7)
The linear stability of E0 can be established using the next generation operator method on the system (3). Using the
notation in [34], the matrices F and V , for the new infection terms and the remaining transfer terms, are, respectively,
given by
F =
⎛
⎜⎜⎜⎜⎜⎝
0 0 0 c f β f c f β f θ1 c f β f θ2
0 0 0 0 0 0
0 0 0 0 0 0
cmβm cmβmθ1 cmβmθ2 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
⎞
⎟⎟⎟⎟⎟⎠ ,
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V =
⎛
⎜⎜⎜⎜⎜⎝
k1 0 0 0 0 0
−κmρm k2 −(1− φm)γm 0 0 0
−(1− κm)ρm 0 k3 0 0 0
0 0 0 k4 0 0
0 0 0 −κ f ρ f k5 −(1− φ f )γ f
0 0 0 −(1− κ f )ρ f 0 k6
⎞
⎟⎟⎟⎟⎟⎠ ,
where
k1 = μ + ρm, k2 = μ + δm + θm, k3 = μ + δm + γm,
k4 = μ + ρ f , k5 = μ + δ f + θ f , k6 = μ + δ f + γ f .
Thus,
R0 = ρ
(
F V−1
)=√R0mR0 f , (8)
with
R0m = c f β f
k1
{
1+ ρmθ1ω11 + ρmθ2k2(1− κm)
k2k3
}
, R0 f = cmβmk4
{
1+ ρ f θ1ω21 + ρ f θ2k5(1− κ f )
k5k6
}
,
and ω11 = κmk3 + (1− φm)γm(1− κm), ω21 = κ f k6 + (1− φ f )γ f (1− κ f ). In (8), ρ represents the spectral radius.
Consequently, the following result follows from Theorem 2 of [34].
Lemma 2. The DFE of the basic model (3), given by (7), is locally asymptotically stable (LAS)whenever R0 < 1, and unstable if R0 > 1.
The threshold quantity R0 is the basic reproduction number for Chlamydia infection. It measures the average number
of new Chlamydia infections generated by a single infected individual in a completely susceptible population [12,34]. The
quantity R0 is a composite product of the reproduction numbers for the males (R0m) and females (R0 f ), respectively.
That is, while R0m measures the average number of new Chlamydia infections in the male population generated by a
single infected female introduced into a completely susceptible male population, R0 f measures the average number of new
Chlamydia infections in the female population generated by a single infected male introduced into a completely susceptible
female population.
Lemma 2 implies that Chlamydia can be eliminated from the community (when R0 < 1) if the initial sizes of the sub-
populations of the model are in the basin of attraction of the DFE (E0). To ensure that disease elimination is independent
of the initial sizes of the sub-populations, it is necessary to show that the DFE is globally-asymptotically stable (GAS) if
R0 < 1. This is explored for a special case in Section 2.4.
2.3. Existence of backward bifurcation
Before investigating the global asymptotic dynamics of the DFE, it is instructive to determine the number of equilibrium
solutions the model (3) can have. To do so, let E1 = (S∗∗m , E∗∗m , I∗∗m , A∗∗m , S∗∗f , E∗∗f , I∗∗f , A∗∗f ) be any arbitrary equilibrium of the
basic model (3). Further, let
λ∗∗m =
c f βm(E∗∗m + θ1 I∗∗m + θ2A∗∗m )
N∗∗m
and λ∗∗f =
cmβ f (E∗∗f + θ1 I∗∗f + θ2A∗∗f )
N∗∗f
(9)
be the associated forces of infection for males and females, respectively, at steady-state. To ﬁnd conditions for the existence
of an equilibrium for which Chlamydia infection is endemic in the population (i.e., at least one of E∗∗m , I∗∗m , A∗∗m , E∗∗f , I
∗∗
f
and A∗∗f is non-zero), the equations in (3) are solved in terms of the aforementioned forces of infection at steady-state
(λ∗∗f and λ
∗∗
m ). Setting the right-hand sides of the basic model to zero (at steady state) gives
S∗∗m =
Πm + ψmR∗∗m
λ∗∗f + μ
≡ Πm[C1λ
∗∗
f + k1k2k3t1]
C1(λ∗∗f )2 + C2λ∗∗f + C3
, E∗∗m =
λ∗∗f (S
∗∗
m + rmR∗∗m )
k1
≡ Πmk2k3(t1 + rmλ
∗∗
f )λ
∗∗
f
C1(λ∗∗f )2 + C2λ∗∗f + C3
,
I∗∗m =
ρmκmE∗∗m + γm(1− φm)A∗∗m
k2
≡ ρmΠmλ
∗∗
f (t1 + rmλ∗∗f )ω11
C1(λ∗∗f )2 + C2λ∗∗f + C3
,
A∗∗m =
ρm(1− κm)E∗∗m
k3
≡ ρmΠmk2λ
∗∗
f (t1 + rmλ∗∗f )(1− κm)
C1(λ∗∗)2 + C2λ∗∗ + C3 , R
∗∗
m =
θmI∗∗m + φmγmA∗∗m
t1 + rmλ∗∗ ≡
Πmλ
∗∗
f ω12
C1(λ∗∗)2 + C2λ∗∗ + C3 ,f f f f f
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Π f + ψ f R∗∗f
λ∗∗m + μ ≡
Π f [D1λ∗∗m + k4k5k6t2]
D1(λ∗∗m )2 + D2λ∗∗m + D3 , E
∗∗
f =
λ∗∗m (S∗∗f + r f R∗∗f )
k4
≡ Π f k5k6(t2 + r f λ
∗∗
m )λ
∗∗
m
D1(λ∗∗m )2 + D2λ∗∗m + D3 ,
I∗∗f =
ρ f κ f E∗∗f + γ f (1− φ f )A∗∗f
k5
≡ ρ f Π f λ
∗∗
m (t2 + r f λ∗∗m )ω21
D1(λ∗∗m )2 + D2λ∗∗m + D3 ,
A∗∗f =
ρ f (1− κ f )E∗∗f
k6
≡ ρ f Π f k5λ
∗∗
m (t2 + r f λ∗∗m )(1− κ f )
D1(λ∗∗m )2 + D2λ∗∗m + D3 , R
∗∗
f =
θ f I∗∗f + φ f γ f A∗∗f
t2 + r f λ∗∗m ≡
Π f λ
∗∗
m ω22
D1(λ∗∗m )2 + D2λ∗∗m + D3 ,
(10)
with
t1 = μ + ψm, t2 = μ + ψ f , C1 = rm(k1k2k3 − ω12), C2 = μ(C1 + k1k2k3) + ψm(k1k2k3 − ω12),
C3 = μk1k2k3t1 D1 = rm(k4k5k6 − ω22), D2 = μ(D1 + k4k5k6) + ψ f (k4k5k6 − ω22), D3 = μk4k5k6t2,
ω12 = ρm
[
θmω11 + φmγmk2(1− κm)
]
, ω22 = ρ f
[
θ f ω21 + φ f γ f k5(1− κ f )
]
, (11)
where
k1k2k3 − ω12 = μk2k3 + ρm(μ + δm)
[
μ + δm + (1− κm)θm + γm(1− φm) + γmφmκm
]
,
k4k5k6 − ω22 = μk5k6 + ρ f (μ + δ f )
[
μ + δ f + (1− κ f )θ f + γ f (1− φ f ) + γ f φ f κ f
]
.
Substituting (10) with (11) into the expressions for λ∗∗f and λ
∗∗
m in (9) gives
λ∗∗m =
λ∗∗f a11(t1 + rmλ∗∗f )
(λ∗∗f )2a12 + λ∗∗f a13 + a14
, λ∗∗f =
λ∗∗m a21(t2 + r f λ∗∗m )
(λ∗∗m )2a22 + λ∗∗m a23 + a24 , (12)
where
a11 = βmR0mk1k2k3
β f
, a12 = rm
[
k2k3 + ρmω11 + ρmk2(1− κm)
]
, a13 = ω12(1− rm) + rmk1k2k3 + t1a12
rm
,
a14 = k1k2k3t1, a21 = β f R0 f k4k5k6
βm
, a22 = r f
[
k5k6 + ρ f ω21 + ρ f k5(1− κ f )
]
,
a23 = ω22(1− r f ) + r f k4k5k6 + t2a22r f , a24 = k4k5k6t2,
so that the non-zero (endemic) equilibria of the basic model (3) satisfy:
D1
(
λ∗∗m
)4 + D2(λ∗∗m )3 + D3(λ∗∗m )2 + D4λ∗∗m + D5 = 0, (13)
with
D1 = a21r f (a21a12 + a13a22) + a14a222,
D2 = a22(a21t2a13 + a14a23) + 2a221r f a12t2 + a22(a14a23 − a21r f a11t1) + a21r f (a13a23 − a21a11rmr f ),
D3 = a14a22a24
(
2− R20
)+ a23(a14a23 − a11a21t1r f ) + a221a12t22 + a21t2(a13a23 − a21a11rmr f )
+ a21r f (a13a24 − a11a21rmt2),
D4 = a14a23a24
(
1− R20
)+ a24(a14a23 − a11a21t1r f ) + a21t2(a13a24 − a11a21rmt2),
D5 = a14a224
(
1− R20
)
. (14)
It can easily be seen from (14) that D1 > 0 (since all the model parameters are non-negative). Further, D5 > 0 whenever
R20 < 1 (R0 < 1). Thus, the number of possible positive real roots the polynomial (13) can have depends on the signs of D2,
D3 and D4. This can be analyzed using the Descartes Rule of Signs on the quartic f (x) = D1x4 + D2x3 + D3x2 + D4x+ D5,
given in (13) (with x = λ∗∗m ). The various possibilities for the roots of f (x) are tabulated in Table 1.
The following results (Theorem 2 and Lemma 3) follow from the various possibilities enumerated in Table 1:
Theorem 2. The Chlamydia model (3)
(i) has a unique endemic equilibrium if R0 > 1 and whenever Cases 1, 2, 3 and 6 are satisﬁed;
(ii) could have more than one endemic equilibrium if R0 > 1 and Cases 4, 5, 7 and 8 are satisﬁed;
(iii) could have 2 or more endemic equilibria if R0 < 1 and Cases 2–8 are satisﬁed.
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Number of possible positive real roots of f (x) for R0 < 1 and R0 > 1.
Cases D1 D2 D3 D4 D5 R0 Number of sign changes No of possible positive
real roots (endemic equilibrium)
1 + + + + + R0 < 1 0 0
+ + + + − R0 > 1 1 1
2 + − − − + R0 < 1 2 0, 2
+ − − − − R0 > 1 1 1
3 + + − − + R0 < 1 2 0, 2
+ + − − − R0 > 1 1 1
4 + − + − + R0 < 1 4 0, 2, 4
+ − + − − R0 > 1 3 1, 3
5 + − − + + R0 < 1 2 0, 2
+ − − + − R0 > 1 3 1, 3
6 + + + − + R0 < 1 2 0, 2
+ + + − − R0 > 1 1 1
7 + + − + + R0 < 1 2 0, 2
+ + − + − R0 > 1 3 1, 3
8 + − + + + R0 < 1 2 0, 2
+ − + + − R0 > 1 3 1, 3
Fig. 1. Bifurcation diagram for the basic model (3). Parameter values used are: cm = 10, c f = 10Nm(t)N f (t) , ψm = 0.005, βm = 0.003, β f = 0.0045, θm = θ f = 0.9,
φm = φ f = 0.9, rm = 20.8, r f = 20.5, δm = δ f = 0 (so that, R0m = 0.9246, R0 f = 0.6259 and R0 = 0.7607). All other parameters as in Table 2.
The existence of multiple endemic equilibria when R0 < 1 (shown in Table 1) suggests the possibility of backward
bifurcation (see [29,39,40] and the references therein), where the stable DFE co-exists with a stable endemic equilibrium,
when the reproduction number is less than unity. This is explored below via numerical simulations (rigorous result can be
obtained using Centre Manifold Theory (see, for instance, [30] and the references therein)).
The backward bifurcation phenomenon is illustrated by simulating the model (3) with the following set of parameter
values: cm = 10, c f = 10Nm(t)N f (t) , ψm = 0.005, βm = 0.003, θm = θ f = 0.9, φm = φ f = 0.9, rm = 20.8, r f = 20.5, δm = δ f = 0 and
with other parameters as in Table 2 (so that, R0m = 0.9246, R0 f = 0.6259 and R0 = 0.7607). Fig. 1 depicts the associated
backward bifurcation diagram. Further simulations show that for the case when R0 < 1, the proﬁles can converge to either
the DFE or an endemic equilibrium point (EEP), depending on the initial sizes of the sub-populations of the model (owing
to the phenomenon of backward bifurcation). Fig. 2A shows convergence to both the DFE and the EEP for the total infected
male population when R0 < 1. A similar plot for the total infected female population is depicted in Fig. 2B. It is worth
stating that, for the set of parameter values used, the simulations have to be ran for a long-time period (in thousands of
104 O. Sharomi, A.B. Gumel / J. Math. Anal. Appl. 356 (2009) 96–118Fig. 2. Backward bifurcation diagram for the basic model (3) showing the total number of infected males as a function of time, using various initial
conditions. Parameter values used are: cm = 10, c f = 10Nm(t)N f (t) , ψm = 0.005, βm = 0.003, β f = 0.0045, θm = θ f = 0.9, φm = φ f = 0.9, rm = 20.8, r f = 20.5,
δm = δ f = 0 (so that, R0m = 0.9246, R0 f = 0.6259 and R0 = 0.7607). All other parameters as in Table 2.
years). To the authors knowledge, this is, perhaps, the ﬁrst time backward bifurcation phenomenon has been established in
Chlamydia transmission dynamics.
The epidemiological consequence of this result is that the effective control of Chlamydia in a population (when R0 < 1)
is dependent on the initial sizes of the sub-populations of the model (the disease would persist if the number is high, and
can be eliminated otherwise).
Lemma 3. The Chlamydia model (3) has at least one positive endemic equilibrium whenever R0 > 1, and could have zero, two, or four
positive endemic equilibria whenever R0 < 1.
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In this section, the role of re-infection of recovered males (rm) and females (r f ) on backward bifurcation will be inves-
tigated.
2.4.1. Global stability of DFE when rm = r f = 0
Consider the model (3) in the absence of re-infection of males and females (i.e., rm = r f = 0). We claim the following
Theorem 3. Consider the basic model (3) with rm = r f = 0. The DFE, given by (7), is GAS in D whenever R0  1.
Proof. Consider the following candidate Lyapunov function:
F = a1Em + a2 Im + a3Am + a4E f + a5 I f + a6A f ,
where
a1 = cmβmz1z2k4k5k6, a2 = cmβmθ1z2k1k3k4k5k6, a3 = cmβm
[
θ1(1− φm)γm + θ2k2
]
z2k1k4k5k6,
a4 = k1k2k3k4k5k6R0z2, a5 = k1k2k3k24k5k26R0θ1, a6 = k1k2k3k24k5k6R0
[
θ1(1− φ f )γ f + θ2k5
]
,
z1 = k2k3 + ρmθ1κmk3 + ρmθ1(1− φm)γm(1− κm) + ρmθ2k2(1− κm),
z2 = k5k6 + ρ f θ1κ f k6 + ρ f θ1(1− φ f )γ f (1− κ f ) + ρ f θ2k5(1− κ f ),
with Lyapunov derivative (where a dot represents differentiation with respect to t) given by
F˙ = a1 E˙m + a2 I˙m + a3 A˙m + a4 E˙ f + a5 I˙ f + a6 A˙ f
= cmβmz1z2k4k5k6(λ f Sm − k1Em) + cmβmθ1z2k1k3k4k5k6
(
κmρmEm − k2 Im + (1− φm)γmAm
)
+ cmβm
(
θ1(1− φm)γm + θ2k2
)
z2k1k4k5k6
[
(1− κm)ρmEm − k3Am
]
+ k1k2k3k4k5k6R0z2(λmS f − k4E f ) + k1k2k3k24k5k26R0
(
κ f ρ f E f − k5 I f + (1− φ f )γ f A f
)
+ k1k2k3k24k5k6R0
(
θ1(1− φ f )γ f + θ2k5
)[
(1− κ f )ρ f E f − k6A f
]
= cmβmz1z2k4k5k6λ f Sm − cmβmz2k1k2k3k4k5k6(Em + θ1 Im + θ2Am)
+ k1k2k3k4k5k6R0z2λmS f − k1k2k3k24k25k26R0(E f + θ1 I f + θ2A f )
= cmβmz1z2k4k5k6λ f Sm − z2k1k2k3k4k5k6λmN f
+ k1k2k3k4k5k6R0z2λmS f − k1k2k3k
2
4k
2
5k
2
6R0λ f Nm
c f β f
= k1k2k3k
2
4k
2
5k
2
6R0λ f Nm
c f β f
(
cmc f βmβ f z1z2Sm
k1k2k3k4k5k6R0Nm − 1
)
+ z2k1k2k3k4k5k6λmN f
(R0S f
N f
− 1
)

k1k2k3k24k
2
5k
2
6R0λ f Nm
c f β f
(R0 − 1) + z2k1k2k3k4k5k6λmN f (R0 − 1) 0 for R0  1.
Since all the model parameters and variables are non-negative, it follows that F˙  0 for R0  1 with F˙ = 0 if and only if
E f = I f = A f = Em = Im = Am = 0. Hence, F is a Lyapunov function on D. Thus, using the Lasalle Invariance Principle [11],
E f → 0, I f → 0, A f → 0, Em → 0, Im → 0 and Am → 0 as t → ∞. Substituting E f = I f = A f = Em = Im = Am = 0 in (3)
shows that Rm → 0, Sm → S∗m , R f → 0 and S f → S∗f as t → ∞. Thus, every solution to the equations of the model (3) with
rm = r f = 0, with initial conditions in D, approaches the DFE E0 as t → ∞ whenever R0  1. 
The epidemiological signiﬁcance of the above result is that, in the absence of re-infection for recovered males and
females (rm = r f = 0), Chlamydia will be eliminated from the community if the threshold quantity, R0, can be brought to a
value less than, or equal to, unity.
2.4.2. Existence of a unique endemic equilibrium when rm = r f = 0
In the absence of re-infection of recovered individuals (i.e., rm = r f = 0), the coeﬃcients Di (i = 1..5) in (14) reduce to
D1 = 0, D2 = 0, D3 = a23(a14a23 + a21t2a13),
D4 = a14a23a24
(
1− R20
)+ a24(a14a23 + a21t2a13), D5 = a14a224(1− R20). (15)
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values used are: φm = φ f = 0.5, βm = β f = 0.005, rm = r f = 0 (so that, R0m = 0.9044, R0 f = 0.9290 and R0 = 0.9166). All other parameters as in Table 2.
Thus, the polynomial (13) now becomes g(λ) = λ(a23λ + a24)(D3λ + D5). Solving g(λ) = 0 gives the roots λ1 = 0 (cor-
responding to the DFE, E0), λ2 = − a24a23 < 0 and λ3 = −
D5
D3
< 0 whenever R20  1 (R0  1). Hence, in this case (with
rm = r f = 0), no endemic equilibrium exists whenever R20  1 (R0  1). It follows then that, owing to the absence of
multiple endemic equilibria for the model (3) with rm = r f = 0 and R0 < 1, backward bifurcation is unlikely for the model
(3) if rm = r f = 0 and R0 < 1. Further, for R20 > 1 (R0 > 1), the roots λ2 < 0 and λ3 > 0 conﬁrming the existence of a
unique positive equilibrium (corresponding to λ3 > 0) when R0 > 1. We claim the following results.
Theorem 4. In the absence of re-infection (i.e., rm = r f = 0), the Chlamydia model (3) has a unique endemic equilibrium whenever
R0 > 1, and no endemic equilibrium otherwise.
Theorem 5. In the absence of re-infection (i.e., rm = r f = 0), the Chlamydia model (3) does not undergo backward bifurcation.
Proof. It follows from Theorem 4 (where no endemic equilibrium exists when R0 < 1) and Theorem 3 (where the DFE is
GAS in D whenever R0  1 and rm = r f = 0). 
Fig. 3 depicts the scenario when rm = r f = 0 and R0 < 1 (where the solutions converged to the DFE in line with
Theorem 3).
Theorem 6. Consider the model (3) with 0 rm, r f  1. The model (3) has no endemic equilibrium if R0 < 1.
Proof. Clearly, the coeﬃcients D1 > 0, D2 > 0, D3 > 0, D4 > 0 and D5 > 0 for 0 rm, r f  1 and R0 < 1. Hence the result
follows from Case 1 of Table 1. 
The absence of multiple endemic equilibria when 0 < rm, r f  1 suggests that the DFE of the model (3) is GAS when
R0 < 1. We offer the following conjecture.
Conjecture 1. The DFE of the Chlamydia model (3), given by (7), is GAS in D whenever 0 < rm  1, r f  1 and R0  1.
Figs. 4A and B show simulation results converging to the DFE when 0 < rm, r f  1 and R0 < 1 (in line with the conjec-
ture).
3. Extended model with treatment
In order to qualitatively asses the impact of therapeutic treatment against Chlamydia, the basic model (3) is now ex-
tended to incorporate the use of treatment for individuals with symptoms of the disease. New variables for treated males
O. Sharomi, A.B. Gumel / J. Math. Anal. Appl. 356 (2009) 96–118 107Fig. 4. Time series of the basic model (3) showing the total number of infected males as a function of time, using various initial conditions. Parameter
values used are: φm = φ f = 0.5, βm = β f = 0.005 (so that, R0m = 0.9044, R0 f = 0.9290 and R0 = 0.9166). All other parameters as in Table 2.
(Tm) and females (T f ) are introduced. Symptomatic males (females) are treated at a rate αm (α f ). Treated individuals re-
cover at a rates ηm (η f ) for males (females). Furthermore, treated individuals may fail treatment at a rate ωm (ω f ) for
males (females). Upon failing treatment, a fraction, σm (σ f ) for males (females), will show symptoms of Chlamydia again
(and move to class Im (I f )), while the remaining fraction, (1 − σm) (1 − σ f ) for males (females), will not show symptoms
(and move to asymptomatic class Am (A f )). Individuals feared exposed to the disease are screened (e.g., via contact trac-
ing of conﬁrmed cases) for Chlamydia. Those who are positively identiﬁed, and show no symptoms are treated at rates
τmαm (τ f α f ) with 0 < τm, τ f < 1 for males (females). The parameters 0 < τm, τ f < 1 account for the reduced treatment
rate for asymptomatic individuals in comparison to those with symptoms (in other words, τm and τ f represent the eﬃcacy
of the screening process to capture infected individuals with no symptoms). Finally, it is assumed that treated individuals
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missibility of treated individuals in comparison to untreated infected individuals. Thus, the forces of infection for males and
females, λm and λ f , are now given, respectively, by
λm(t) = c f βm[Em(t) + θ1 Im(t) + θ2Am(t) + θ3Tm(t)]
Nm(t)
, (16)
and
λ f (t) = cmβ f [E f (t) + θ1 I f (t) + θ2A f (t) + θ3T f (t)]N f (t) . (17)
Using these deﬁnitions and assumptions in the basic model (3) results in the following two-group, deterministic, continuous-
time model for the transmission dynamics of Chlamydia in the presence of treatment (a ﬂow diagram of the model is given
in Fig. 5; and the associated variables and parameters are described in Table 2).
dSm
dt
= Πm + ψmRm(t) − λ f (t)Sm(t) − μSm(t),
dEm
dt
= λ f (t)Sm(t) + rmλ f (t)Rm(t) − (μ + ρm + τmαm)Em(t),
dIm
dt
= κmρmEm(t) + (1− φm)γmAm(t) + ωmσmTm(t) − (μ + δm + αm + θm)Im(t),
dAm
dt
= (1− κm)ρmEm(t) + ωm(1− σm)Tm(t) − (μ + δm + γm + τmαm)Am(t),
dTm
dt
= αmIm(t) + τmαm
(
Em(t) + Am(t)
)− (μ + ηm + ωm)Tm(t),
dRm
dt
= ηmTm(t) + φmγmAm(t) + θmIm(t) −
(
ψm + μ + rmλ f (t)
)
Rm(t),
dS f
dt
= Π f + ψ f R f (t) − λm(t)S f (t) − μS f (t),
dE f
dt
= λm(t)S f (t) + r f λm(t)R f (t) − (μ + ρ f + τ f α f )E f (t),
dI f
dt
= κ f ρ f E f (t) + (1− φ f )γ f A f (t) + ω f σ f T f (t) − (μ + δ f + α f + θ f )I f (t),
dA f
dt
= (1− κ f )ρ f E f (t) + ω f (1− σ f )T f (t) − (μ + δ f + γ f + τ f α f )A f (t),
dT f
dt
= α f I f (t) + τmαm
(
E f (t) + A f (t)
)− (μ + η f + ω f )T f (t),
dR f
dt
= η f T f (t) + φ f γ f A f (t) + θ f I f (t) −
(
ψ f + μ + r f λm(t)
)
R f (t). (18)
3.1. Basic properties
3.1.1. Positivity and boundedness of solutions
The approach in Section 2.2.1 can be used to prove the following result.
Theorem 7. Let the initial data Sm(0)  0, Em(0)  0, Im(0)  0, Am(0)  0, Tm(0)  0, Rm(0)  0, S f (0)  0, E f (0)  0,
I f (0)  0, A f (0)  0, T f (0)  0, R f (0)  0. Then the solutions (Sm, Em, Im, Am, Tm, Rm, S f , E f , I f , A f , T f , R f ) of the system
(18) are positive for all t > 0. Furthermore,
limsup
t→∞
Nm(t)
Πm
μ
and limsup
t→∞
N f (t)
Π f
μ
,
with
Nm = Sm + Em + Im + Am + Tm + Rm and N f = S f + E f + I f + A f + T f + R f .
3.1.2. Invariant regions
Consider the biologically-feasible region
Γ = Γm ∪ Γ f ⊂R6+ ×R6+,
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Description of variables and parameters for treatment model (18).
Variables Description
Sm(t), S f (t) Population of susceptible males and females
Em(t), E f (t) Population of exposed males and females
Im(t), I f (t) Population of infectious males and females showing symptoms of Chlamydia
Am(t), A f (t) Population of infectious males and females not showing symptoms of Chlamydia
Tm(t), T f (t) Population of treated males and females
Rm(t), R f (t) Population of recovered males and females
Parameters Description Nominal values (year)−1 Reference
Πm , Π f Recruitment rates for males and females 1000, 1000 Assumed
βm , β f Probability of transmission for males and females 0.11, 0.11 [20,25]
cm , c f Rate of acquisition of new sexual partners for males and females 10,
10Nm(t)
N f (t)
[3,20,21,26]
θ1, θ2, θ3 Modiﬁcation parameters for infectiousness 1.2, 1.5, 0.05 Assumed
ψm , ψ f Rate of loss of immunity for males and females 0.5, 0.5 Assumed
κm , κ f Fraction of infectious individuals that shows symptoms for males and females 0.5, 0.25 [4]
ρm , ρ f Rate of symptoms development for exposed males and females 2/52, 2/52 [4]
τm , τ f Probabilities 0.3, 0.3 Assumed
rm , r f Re-infection parameters for males and females 0.11, 0.35 [9,23]
μ Natural death rate 1/70 Assumed
γm , γ f Rate at which males and females leave the asymptomatic class 3.65, 1.971 Assumed
δm , δ f Disease-induced mortality rate for males and females 0.001, 0.001 [33]
αm , α f Treatment rate for males and females 5, 5 Assumed
ωm , ω f Treatment failure rate for males and females 0.01, 0.01 Assumed
σm , σ f Fraction of males and females showing symptoms after treatment failure 0.9, 0.9 Assumed
ηm , η f Recovery rates for males and females 0.05, 0.05 Assumed
θm , θ f Natural clearance rate for males and females showing symptoms of Chlamydia (0.025–0.03)*365 [3,20,22,24]
φmγm , φ f γ f Natural clearance rate for males and females in the asymptomatic class (0.0027–0.005)*365 [3,20,22,24]
with
Γm =
{
(Sm, Em, Im, Am, Tm, Rm) ∈R6+: Sm + Em + Im + Am + Tm + Rm 
Πm
μ
}
,
Γ f =
{
(S f , E f , I f , A f , T f , R f ) ∈R6+: S f + E f + I f + A f + T f + R f 
Π f
μ
}
.
Using the same approach as in Section 2.2, it can be shown that Γ is a positively-invariant region for the treatment
model (18).
3.2. Stability of DFE
3.2.1. Local stability
The treatment model (18) has a DFE, given by
E0T =
(
S∗m, E∗m, I∗m, A∗m, T ∗m, R∗m, S∗f , E
∗
f , I
∗
f , A
∗
f , T
∗
f , R
∗
f
)= (Πm
μ
,0,0,0,0,0,
Π f
μ
,0,0,0,0,0
)
. (19)
Here, the next generation matrices (denoted by F2 and V2) are given, respectively, by
F2 =
⎛
⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 c f β f c f β f θ1 c f β f θ2 c f β f θ3
0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0
cmβm cmβmθ1 cmβmθ2 cmβmθ3 0 0 0 0
0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0
⎞
⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
,
and
V2 =
⎛
⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
q1 0 0 0 0 0 0 0
−κmρm q2 −(1− φm)γm −ωmσm 0 0 0 0
−(1− κm)ρm 0 q3 −ωm(1− σm) 0 0 0 0
−τmαm −αm −τmαm q4 0 0 0 0
0 0 0 0 q6 0 0 0
0 0 0 0 −κ f ρ f q7 −(1− φ f )γ f −ω f σ f
0 0 0 0 −(1− κ f )ρ f 0 q8 −ω f (1− σ f )
⎞
⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
,0 0 0 0 −τ f α f −α f −τ f α f q9
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q1 = μ + ρm + τmαm, q2 = μ + δm + αm + θm, q3 = μ + δm + γm + τmαm,
q4 = μ + ηm + ωm, q5 = μ + ψm, q6 = μ + ρ f + τ f α f , q7 = μ + δ f + α f + θ f ,
q8 = μ + δ f + γ f + τ f α f , q9 = μ + η f + ω f , q10 = μ + ψ f .
Thus,
RT = ρ
(
F2V
−1
2
)=√RmT R f T , (20)
with
RmT = c f β f
q1
(
1+ b11θ1 + b12θ2 + b13θ3
b14
)
,
R f T = cmβmq6
(
1+ b21θ1 + b22θ2 + b23θ3
b24
)
,
and
b11 = αmωmτm
[
σm(q3 + ρm) + γm(1− σm)(1− φm)
]+ ρmq4[γm(1− κm)(1− φm) + κm(μ + δm + γm)]
+ ρmκmτmαm(μ + ηm),
b12 = ρm(1− κm)
[
q4(μ + δm + θm) + αm(μ + ηm)
]+ ωmαm(1− σm)(τmq2 + ρm),
b13 = αmτmq2q3 + αmρm
[
κmq3 + γm(1− φm)(1− κm) + τmq2(1− κm)
]
,
b14 = (μ + δm + γm)
[
q4(μ + δm + θm) + αm(μ + ηm)
]+ αmωm(1− σm)(μ + δm + φmγm)
+ τmαm
[
q2(μ + ηm) + ωmσm(μ + δm + θm)
]
,
b21 = α f ω f τ f
[
σ f (q8 + ρ f ) + γ f (1− σ f )(1− φ f )
]+ ρ f q9[γ f (1− κ f )(1− φ f ) + κ f (μ + δ f + γ f )]
+ ρ f κ f τ f α f (μ + η f ),
b22 = ρ f (1− κ f )
[
q9(μ + δ f + θ f ) + α f (μ + η f )
]+ ω f α f (1− σ f )(τ f q7 + ρ f ),
b23 = α f τ f q7q8 + α f ρ f
[
κ f q8 + γ f (1− φ f )(1− κ f ) + τ f q7(1− κ f )
]
,
b24 = (μ + δ f + γ f )
[
q9(μ + δ f + θ f ) + α f (μ + η f )
]+ α f ω f (1− σ f )(μ + δ f + φ f γ f )
+ τ f α f
[
q7(μ + η f ) + ω f σ f (μ + δ f + θ f )
]
.
The following result follows from Theorem 2 of [34].
Lemma 4. The DFE of the Chlamydia treatment model (18), given by (19), is LAS whenever RT < 1, and unstable if RT > 1.
The quantity RT is the treatment reproduction number for Chlamydia infection. It measures the average number of new
Chlamydia infection generated by a single infected individual in a population where certain fraction of infected individuals
are treated. Here, the two quantities RmT and R f T are the reproduction numbers for the males and females, respectively.
The quantity RmT measures the average number of new Chlamydia infections in the male population generated by a single
infected female in a susceptible male population where a certain fraction of infected individuals are treated. Similarly, the
quantity R f T measures the average number of new Chlamydia infections in the female population generated by a single
infected male in a susceptible female population in the presence of treatment.
3.3. Threshold analysis
In order to qualitatively measure the impact of treatment on Chlamydia transmission dynamics, a sensitivity analysis on
the treatment-related parameters (αm and α f ) of the model (18) is carried out by computing the partial derivatives of RT
with respect to these parameters. First of all, starting with
RT =
√
RmT R f T ,
it follows that
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∂αm
= ∂
∂αm
(
√
R f T RmT ) =
√
RmT ∂
∂αm
√
R f T +
√
R f T ∂
∂αm
√
RmT
= (
√
RmT )(0) +
√
R f T ∂
∂αm
√
RmT =
√
R f T ∂
∂αm
√
RmT .
Similarly,
∂RT
∂α f
=
√
RmT ∂
∂α f
√
R f T .
Thus, ∂RT
∂αm
> 0 (< 0) and ∂RT
∂α f
> 0 (< 0) if ∂
∂αm
√RmT > 0 (< 0) and ∂∂α f
√R f T > 0 (< 0), respectively.
Further,
∂
∂αm
√
RmT = 1
2
√RmT
∂RmT
∂αm
= c f β f
2
√RmT
∂
∂αm
[
1
q1
+ b11θ1 + b12θ2 + b13θ3
q1b14
]
= c f β f
2
√RmT
[−q′1
q21
+ ∂
∂αm
(
θ1b11
q1b14
)
+ ∂
∂αm
(
θ2b12
q1b14
)
+ ∂
∂αm
(
θ3b13
q1b14
)]
= c f β f
2b214q
2
1
√RmT
[−τmb214 + q1b14(θ1b′11 + θ2b′12 + θ3b′13)− (τmb14 + q1b′14)(θ1b11 + θ2b12 + θ3b13)]. (21)
Letting m = −τmb214 + q1b14(θ1b′11 + θ2b′12 + θ3b′13) − (τmb14 + q1b′14)(θ1b11 + θ2b12 + θ3b13), with
b′11 = ωmτm
[
γm(1− σm)(1− φm) + σm(τmαm + q3 + ρm)
]+ ρmκmτm(μ + ηm),
b′12 = ρm(μ + ηm)(1− κm) + ωm(1− σm)
[
ρm + τm(q2 + αm)
]
,
b′13 = τm(q2q3 + αmτmq2 + αmq3) + ρm
[
γm(1− φm)(1− κm) + κm(αmτm + q3) + τm(1− κm)(αm + q2)
]
,
b′14 = (μ + ηm)(μ + δm + γm) + ωm(1− σm)(μ + δm + φmγm) + τmωmσm(μ + δm + θm) + τm(μ + ηm)(αm + q2),
it follows from (21) that
∂RT
∂αm
= c f β f
√R f T
2b214q1
√RmT
m. (22)
Similarly, it can be shown that
∂RT
∂α f
= cmβm
√RmT
2b224q6
√R f T  f , (23)
with
 f = −τ f b224 + q6b24
(
θ1b
′
21 + θ2b′22 + θ3b′23
)− (τ f b24 + q6b′24)(θ1b21 + θ2b22 + θ3b23),
b′21 = ω f τ f
[
γ f (1− σ f )(1− φ f ) + σ f (τ f α f + q8 + ρ f )
]+ ρ f κ f τ f (μ + η f ),
b′22 = ρ f (μ + η f )(1− κ f ) + ω f (1− σ f )
[
ρ f + τm(q2 + αm)
]
,
b′23 = τ f (q7q8 + α f τ f q7 + α f q8) + ρ f
[
γ f (1− φ f )(1− κ f ) + κ f (α f τ f + q8) + τ f (1− κ f )(α f + q7)
]
,
b′24 = (μ + η f )(μ + δ f + γ f ) + ω f (1− σ f )(μ + δ f + φ f γ f ) + τ f ω f σ f (μ + δ f + θ f ) + τ f (μ + η f )(α f + q7).
It can be easily seen from (22) and (23) that
∂RT
∂αm
< 0 iff m < 0 and
∂RT
∂α f
< 0 iff  f < 0.
Thus, the above analysis shows that the treatment of infected males or females (in the E , A and I classes) will have positive
impact (in reducing the burden of Chlamydia) if and only if the threshold quantity  = max{m, f } < 0 (since a reduction
in RT is analogous to a reduction in disease burden; and  < 0 makes RT a decreasing function of αm and α f ). Such
treatment will fail or have no impact if  0. This result is summarized below.
Lemma 5. The use of treatment will have positive impact if  < 0, no impact if m =  f = 0 and will have detrimental impact if
 > 0.
Note that if treatment is perfect, and every treated individual adheres strictly to treatment guidelines (i.e., θ3 = 0 and
ωm = ω f = 0), then it can be easily shown that m < 0 and  f < 0. Hence, treatment will always have positive impact
(because  < 0 in this case).
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such that φm = φ f = 0.5, θ3 = 0.5, RmT = 8.2732, R f T = 8.3586, RT = 8.3158, m = −3.4875 < 0 and  f = −1.2735 < 0.
3.4. Existence of backward bifurcation
Using similar approach as in Section 2.3 or using the Centre Manifold Theory [30], it can be shown that the treatment
model (18) also exhibits the phenomenon of backward bifurcation. Further, we claim the following result.
Theorem 8. In the absence of re-infection (i.e., rm = r f = 0), the treatment model (18) has a globally stable disease-free equilibrium
whenever RT  1.
Proof. Similar to the proof of Theorem 3. 
Theorem 9. In the absence of re-infection (i.e., rm = r f = 0), the treatment model (18) has a unique endemic equilibrium whenever
RT > 1, and no endemic equilibrium otherwise.
Proof. Similar to the proof of Theorem 4. 
Theorem 10. In the absence of re-infection (i.e., rm = r f = 0), the treatment model (18) does not undergo backward bifurcation.
Proof. Similar to the proof of Theorem 5. 
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such that φm = φ f = 0.5, θ3 = 2, RmT = 30.91, R f T = 31.22, RT = 31.07, m = 17.59 > 0 and  f = 6.19 > 0.
4. Numerical simulations and discussions
The treatment model (18) is simulated using the parameters in Table 2 (unless otherwise stated), to monitor its qualita-
tive dynamics for various values of the associated reproduction thresholds (R f T , RmT and RT ).
4.1. Threshold simulations
Further simulations are carried out to assess the impact of treatment in reducing the burden of Chlamydia in a popula-
tion. Fig. 6 shows that whenever the threshold quantity  < 0, the use of treatment would have positive impact, since the
cumulative number of new cases of infection in the presence of treatment is less than that for the case when treatment is
not used. However, for the case when  > 0, the use of treatment in the community induces detrimental impact since, in
this case, the cumulative number of new cases in the presence of treatment exceeds that for the case when treatment is
not used (this is depicted in Fig. 7). It is worth emphasizing that the results in Figs. 6 and 7 are consistent with Lemma 5.
4.2. Treatment strategies
This study considers three main treatment strategies namely, (i) treating all infected males with Chlamydia only (male-
only strategy), (ii) treating all infected females with Chlamydia only (female-only strategy), (iii) treating all infected individ-
uals with Chlamydia (universal strategy). The impact of these strategies is analyzed as follows.
4.2.1. Male-only treatment strategy
Here, simulations are carried out to monitor the impact of singularly treating all infected males with Chlamydia (i.e.,
the impact of treating individuals in the Im class at a rate αm and those in the Em and Am classes are treated at the rates
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φ f = 0.5, αm = 5, α f = 0 and all other parameters as in Table 2.
τmαm). Using αm = 5, τm = 0.3, the solution proﬁle obtained, depicted in Fig. 8, shows that in addition to averting many
cases of infection in males (at least 2200 new cases), this strategy induces an indirect beneﬁt to the female population (by
averting as many as 4700 new cases in the female population). This result is not surprising since females acquire infection
from males, and effectively treating males should reduce the number of new cases of infection in the female population.
4.2.2. Female-only treatment strategy
In these simulations, all infected females with Chlamydia are treated. That is, individuals in the I f class are treated
(at the rate α f ) and those in the Em and Am classes are treated (at the rate τ f α f ). Fig. 9 shows a similar trend to what
was obtained using the male-only strategy. Here, up to 2300 new female infections and 4800 new male infections can be
averted.
4.2.3. Universal treatment strategy
Here, all infected individuals (both males and females) with Chlamydia are treated. Fig. 10 shows that more new cases
are prevented here, since, on average, at least 7000 new cases of male infections and equal number of female infections can
be averted, respectively.
5. Conclusions
A comprehensive, continuous-time deterministic model for the transmission dynamics of Chlamydia in a population is
designed and rigorously analyzed. The basic model has a locally-asymptotically stable DFE whenever the associated repro-
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φm = φ f = 0.5, αm = 0, α f = 5 and all other parameters as in Table 2.
duction number is less than unity. Further, the basic model is shown to exhibit the phenomenon of backward bifurcation
when the associated reproduction number is less than unity. The basic model is extended to incorporate the use of treat-
ment for individuals infected with Chlamydia. The extended model is also shown to have similar dynamics as the basic
model. By analyzing the reproduction number of the model with treatment, it was shown that the use of treatment can
lead to Chlamydia elimination in the community if a certain threshold quantity, denoted by , is negative (the use of
treatment will have negative impact if  > 0). The treatment model allows for the assessment of three treatment strategies,
namely (a) treating all infected males with Chlamydia, (b) treating all infected females with Chlamydia, and (c) the universal
treatment of all infected individuals with Chlamydia. The strategies are evaluated in terms of their ability to reduce disease
burden (measured based on the number of new cases averted). The main theoretical and epidemiological ﬁndings of this
study are summarized below:
(i) The basic model exhibits the phenomenon of backward bifurcation, where the stable DFE co-exists with a stable en-
demic equilibrium, when the reproduction number is less than unity. It is shown that this (backward bifurcation)
dynamical feature is caused by the re-infection of treated individuals who recovered from the disease. The model with
treatment also exhibits the phenomenon of backward bifurcation;
(ii) The effectiveness of the treatment program (for infectious individuals with Chlamydia symptoms) is dependent on the
sign of a certain epidemiological threshold, denoted by . Treatment will have positive (negative) impact if  < (>)0;
(iii) The singular treatment of individuals of one sex induces an indirect beneﬁt to members of the opposite sex;
(iv) The universal treatment strategy gives the highest reduction in the cumulative number of new cases of Chlamydia, in
comparison to the male-only and female-only treatment strategies.
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φ f = 0.5, αm = 5, α f = 5 and all other parameters as in Table 2.
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